Literature DB >> 28904060

Early Exposure to a High Fat/High Sugar Diet Increases the Mammary Stem Cell Compartment and Mammary Tumor Risk in Female Mice.

Isabel U Lambertz1, Linjie Luo1, Thomas R Berton2, Scott L Schwartz3, Stephen D Hursting4,5, Claudio J Conti6,7, Robin Fuchs-Young8.   

Abstract

Obesity and alterations in metabolic programming from early diet exposures can affect the propensity to disease in later life. Through dietary manipulation, developing mouse pups were exposed to a hyperinsulinemic, hyperglycemic milieu during three developmental phases: gestation, lactation, and postweaning. Analyses showed that a postweaning high fat/high sugar (HF/HS) diet had the main negative effect on adult body weight, glucose tolerance, and insulin resistance. However, dimethylbenz[a]anthracene (DMBA)-induced carcinogenesis revealed that animals born to a mother fed a HF/HS gestation diet, nursed by a mother on a mildly diet-restricted, low fat/low sugar diet (DR) and weaned onto a HF/HS diet (HF/DR/HF) had the highest mammary tumor incidence, while HF/HF/DR had the lowest tumor incidence. Cox proportional hazards analysis showed that a HF/HS postweaning diet doubled mammary cancer risk, and a HF/HS diet during gestation and postweaning increased risk 5.5 times. Exposure to a HF/HS diet during gestation, when combined with a postweaning DR diet, had a protective effect, reducing mammary tumor risk by 86% (HR = 0.142). Serum adipocytokine analysis revealed significant diet-dependent differences in leptin/adiponectin ratio and IGF-1. Flow cytometry analysis of cells isolated from mammary glands from a high tumor incidence group, DR/HF/HF, showed a significant increase in the size of the mammary stem cell compartment compared with a low tumor group, HF/HF/DR. These results indicate that dietary reprogramming induces an expansion of the mammary stem cell compartment during mammary development, increasing likely carcinogen targets and mammary cancer risk. Cancer Prev Res; 10(10); 553-62. ©2017 AACRSee related editorial by Freedland, p. 551-2. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28904060     DOI: 10.1158/1940-6207.CAPR-17-0131

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  6 in total

Review 1.  Weighing the Risk: effects of Obesity on the Mammary Gland and Breast Cancer Risk.

Authors:  Lauren E Hillers-Ziemer; Lisa M Arendt
Journal:  J Mammary Gland Biol Neoplasia       Date:  2020-06-09       Impact factor: 2.673

2.  Puberty is a critical window for the impact of diet on mammary gland development in the rabbit.

Authors:  Cathy Hue-Beauvais; Johann Laubier; Nicolas Brun; Inès Houtia; Florence Jaffrezic; Claudia Bevilacqua; Fabienne Le Provost; Madia Charlier
Journal:  Dev Dyn       Date:  2019-08-02       Impact factor: 3.780

Review 3.  Nutritional Regulation of Mammary Gland Development and Milk Synthesis in Animal Models and Dairy Species.

Authors:  Cathy Hue-Beauvais; Yannick Faulconnier; Madia Charlier; Christine Leroux
Journal:  Genes (Basel)       Date:  2021-04-03       Impact factor: 4.096

4.  Maternal Low-Protein Diet Deregulates DNA Repair and DNA Replication Pathways in Female Offspring Mammary Gland Leading to Increased Chemically Induced Rat Carcinogenesis in Adulthood.

Authors:  Joyce R Zapaterini; Antonio R B Fonseca; Lucas T Bidinotto; Ketlin T Colombelli; André L D Rossi; Laura Kass; Luis A Justulin; Luis F Barbisan
Journal:  Front Cell Dev Biol       Date:  2022-02-01

5.  Early Dietary Exposures Epigenetically Program Mammary Cancer Susceptibility through Igf1-Mediated Expansion of the Mammary Stem Cell Compartment.

Authors:  Yuanning Zheng; Linjie Luo; Isabel U Lambertz; Claudio J Conti; Robin Fuchs-Young
Journal:  Cells       Date:  2022-08-17       Impact factor: 7.666

6.  Fetal Alcohol Exposure Alters Mammary Epithelial Cell Subpopulations and Promotes Tumorigenesis.

Authors:  Mariana Saboya; Amanda E Jetzt; Ketaki Datar; Wendie S Cohick
Journal:  Alcohol Clin Exp Res       Date:  2020-03-04       Impact factor: 3.455

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.